Last reviewed · How we verify

NCT04772833

Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Status unknown Last updated 26 February 2021
What this trial tests

trial testing Autopsy in Covid19 in 50 participants. Status unknown.

Timeline
5 June 2020
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorMaimónides Biomedical Research Institute of Córdoba
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date5 June 2020
Primary completion31 December 2021
Estimated completion31 December 2021
Sites10 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Maimónides Biomedical Research Institute of Córdoba

Who can join

Eligibility, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is prospectively analyzing the histopathological, ultrastructural and microbiological findings from autopsies performed on patients with COVID-19.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Autopsy

Trials testing the same drug.

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Maimónides Biomedical Research Institute of Córdoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04772833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing